Literature DB >> 6890473

Kirromycin-resistant elongation factor Tu from wild-type of Lactobacillus brevis.

W Wörner, H Wolf.   

Abstract

Properties of the elongation factor Tu from Lactobacillus brevis which is naturally insensitive to kirromycin are described. The protein is characterized by an unusual nucleotide-binding site with increased affinity for GTP and extreme heat stability. EF-Tu is sensitive to pulvomycin in the assay of polyphenylalanine synthesis. However, the failure of the protein to display pulvomycin-dependent GDP-binding and GTPase activity indicates that pulvomycin action in L. brevis differs from that in E. coli.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6890473     DOI: 10.1016/0014-5793(82)80944-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.

Authors:  P Landini; M Bandera; B P Goldstein; F Ripamonti; A Soffientini; K Islam; M Denaro
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

2.  Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus.

Authors:  C C Hall; J D Watkins; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Differential susceptibilities of enterococcal species to elfamycin antibiotics.

Authors:  A Miele; B P Goldstein; M Bandera; C Jarvis; A Resconi; R J Williams
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

4.  Comparison of the Tu elongation factors from Staphylococcus aureus and Escherichia coli: possible basis for elfamycin insensitivity.

Authors:  C C Hall; J D Watkins; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

5.  The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.

Authors:  J R Mesters; L A Zeef; R Hilgenfeld; J M de Graaf; B Kraal; L Bosch
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.